How Big Pharma Silenced the White House
A single poll of 1,000 people convinced the White House to tell Robert Kennedy Jr. to stop talking about vaccines. The full results of that same poll were hidden from Trump and his administration. The Daily Caller just published them.
@JeffereyJaxen walks through the sequence. In December 2025, a Fabrizio poll of 1,000 voters in key House districts was circulated to the White House and picked up wall-to-wall by the New York Times and other outlets, with the message that vaccine skepticism was bad politics and that candidates who questioned childhood vaccine requirements would pay at the ballot box.
Kennedy was told to stand down on vaccines and focus on food. The White House obliged. What the Daily Caller has now obtained is the rest of the Fabrizio data, from a poll conducted in October 2025 by Trump's own longtime pollster, that was never released.
The suppressed results show that 73% of voters expressed concern about childhood vaccine mandates, 90% expressed concern about the pharmaceutical industry's corrupting influence over government, politics, medical research, and news coverage, and approximately 70% across all political affiliations want vaccine manufacturer blanket immunity lifted.
Nearly seven in ten voters want more research into vaccines' cumulative effect on infants. The poll that shaped six months of White House vaccine policy told a fraction of the story. The rest was kept from Trump.
Against that backdrop, Trump just signed an executive order directing the CDC and ACIP to review the scientific assessment and latest clinical data and take appropriate steps to update the childhood and adolescent vaccine schedule, with explicit language requiring that all actions fulfill legal obligations with respect to parental authority, religious freedom, disability accommodations, and equal protection.
Dr. Robert Malone, former ACIP co-chair, describes the order as potentially changing the vaccine debate forever, because the phrase "to the extent permitted by law" restores executive branch authority over vaccination policy and strips ACIP of its de facto rule-making power, confining the committee to an advisory role rather than the policy-setting function it has exercised for decades. The Massachusetts judge's stay on the ACIP restructuring had put Kennedy's reform agenda on ice.
This executive order moves around that roadblock.
We should keep our eyes focused on the next ACIP meeting.